Ann: US FDA Type C Meeting for ATL1102 in DMD, page-38

Agree, non clinical means "how are you going to fund this?". Clearly the answer will be via another capital raising and most likely at 10-20% discount to the 14 day vwap, again. So i am expecting, worst case, someone like AEF to be gifted 100M shares @ 18 cents, (and like before, bought @ 3 cents and sold @ 10 cents) they will ramp the share price to 60 cents and dump the lot, or best case like Platinum, they will hold. It is possible the fund is already participating now by capping the price around 20 cents so they get a low CR entry point. Either way by the time this is all over the SP will be 60-80 cents and approaching the end of the trial. Accumulate and hold through all of this and you will be well rewarded.. BTW, I very much doubt that we will see reporting of new indications until the CR raising has been concluded. ANP has always sided more with the insto's/funds than their loyal retail investors.